2-48454605-A-G
Variant summary
Our verdict is Uncertain significance. The variant received 3 ACMG points: 3P and 0B. PM2PP3
The NM_001135629.3(PPP1R21):c.137A>G(p.Lys46Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000198 in 1,614,048 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001135629.3 missense
Scores
Clinical Significance
Conservation
Publications
- neurodevelopmental disorder with hypotonia, facial dysmorphism, and brain abnormalitiesInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 3 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152252Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000318 AC: 8AN: 251342 AF XY: 0.0000221 show subpopulations
GnomAD4 exome AF: 0.0000178 AC: 26AN: 1461796Hom.: 0 Cov.: 31 AF XY: 0.0000151 AC XY: 11AN XY: 727202 show subpopulations
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152252Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74384 show subpopulations
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.137A>G (p.K46R) alteration is located in exon 3 (coding exon 3) of the PPP1R21 gene. This alteration results from a A to G substitution at nucleotide position 137, causing the lysine (K) at amino acid position 46 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at